1.Clinical Consistency Evaluation of Quetiapine Kit Based on Liquid Chromatography Tandem Mass Spectrometry Technology
LI Xuanwei ; LIN Meihua ; ZHAI You ; XU Nana ; LI Xiao ; LYU Duo ; ZHAO Qingwei ; LIU Jian
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1803-1807
OBJECTIVE
To evaluate the consistency between the quetiapine LC-MS/MS kit and the laboratory-built method(reference method) in the detection results of quetiapine therapeutic drug monitoring.
METHODS
A total of 120 remaining plasma samples were collected from patients receiving quetiapine therapeutic drug monitoring from March to October in 2021. The plasma concentration of quetiapine was detected by kit and reference method respectively. The analysis of correlations and consistency was performed by outlier analysis, linear regression and Bland-Altman method.
RESULTS
No outliers were detected. The linear regression equation was Y=1.018X+4.400(r=0.998), indicating a good correlation. The Bland-Altman plot analysis showed good agreement between the two measurements.
CONCLUSION
The detection results of quetiapine LC-MS/MS kit and reference method are in good agreement. The kit can be used for clinical quetiapine treatment drug monitoring.
2.Rapid Determination of 43 Chemical Drugs in Blood with UHPLC-HRMS
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1808-1812
OBJECTIVE
To establish a UPLC-HRMS method for simultaneous determination of 43 chemical drugs in blood and apply the method to determine the content of 43 chemical drugs in blood of 100 abnormal death from Hangzhou.
METHODS
Proteins were precipitated using acetonitrile. After centrifugation, the supernatant was collected and dried under a nitrogen stream. The residue was reconstituted with the initial mobile phase, centrifuged, and the supernatant was filtered through a 0.22 μm microporous membrane for instrument analysis. Separation was performed using a C18(150 mm×2.1 mm, 3.0 μm) chromatographic column. The mobile phase consisted of 0.1% formic acid+5 mmol ammonium formate(phase A) and methanol+0.1% formic acid(phase B) with gradient elution. Mass spectrometric detection was carried out using an electrospray ionization source(HESI-II) with simultaneous positive and negative ion scanning and real-time tandem mass spectrometry scanning(Full MS/ddMS2).
RESULTS
The linearity of 43 chemical drugs within the range of 10 to 1000 ng·mL−1 was good, with r2 ranging from 0.9910 to 0.9998; the limit of quantification was 10 ng·mL−1; the matrix effect was between 79.4% and 99.7%; the method recovery rate was between 80.4% and 97.0%; the intra-day precision(RSD) ranged from 0.1% to 3.2%; and the inter-day precision(RSD) ranged from 0.6% to 9.8%. Using this method, 100 whole blood samples from the Hangzhou Public Security Judicial Identification Center were tested, with 2 samples detected, both of which contained sibutramine.
CONCLUSION
The method is sensitive and accurate for fast detection of 43 chemical drugs in human blood.
3.Clinical Efficacy of Quadruple Regimen Including Clarithromycin Sustained-Release Tablets for Primary Eradication of Helicobacter Pylori
YANG Bo ; LYU Lisong ; XIN Chuanwei
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1813-1817
OBJECTIVE
To explore the clinical efficacy of clarithromycin sustained-release tablets in the primary eradication of Helicobacter pylori.
METHODS
Retrospective analysis of the data of patients with primary eradication of Helicobacter pylori admitted to the outpatient department of Tongde Hospital of Zhejiang Province from January 2019 to December 2020 was conducted. They were divided into three groups according to the choice of clarithromycin dosage form and dosage, namely, clarithromycin tablets 500 mg bid treatment group(group A), clarithromycin sustained-release tablets 500 mg bid treatment group(group B), and clarithromycin sustained-release tablets 500 mg qd treatment group(group C). At least 4 weeks after the end of treatment in each group, telephone follow-up was conducted to compare and analyze the efficacy, compliance, recurrence rate, incidence of adverse reactions, and cost effectiveness ratio of different treatment schemes for eradication.
RESULTS
After eliminating lost visits, a total of 350 cases were included in this study, including 132 cases in group A, 101 cases in group B, and 117 cases in group C. The overall eradication rates in each group were 95.45%, 92.08%, and 97.44%, respectively. Six patients with low compliance were excluded (3 in group A, 3 in group B, and 0 in group C), with eradication rates of 95.35%, 92.86%, and 97.44%, respectively. There was no significant difference in the eradication rate, compliance, recurrence rate, and incidence of adverse reactions among the groups, but the cost effectiveness ratio in group C was the lowest. Taking group A as a reference, the incremental cost effectiveness ratio for group C was ‒156.459.
CONCLUSION
Clarithromycin sustained-release tablets can be safely and effectively used in the primary eradication treatment of patients with Helicobacter pylori infection, and can be used according to the recommended dosage in the instructions.
4.Cost-utility Analysis of PD-1/PD-L1 Inhibitor Combination Therapies as First-line Treatment for Advanced Non-small-cell Lung Cancer
HE Yimin ; NIAN Zilin ; LIU Wenbin ; YANG Lin ; DONG Liangliang ; ZHAO Qiuling
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1820-1829
OBJECTIVE
To compare the cost-utility of eight programmed death 1(PD-1)/programmed cell death-ligand 1(PD-L1) inhibitor combination regimens for first-line treatment of advanced non-small cell lung cancer(NSCLC) from the perspective of Chinese healthcare system.
METHODS
Relevant data were derived from a published network meta-analysis and randomized controlled trails, a three-state Markov model was established to analyze the cost-utility of eight immunotherapy combinations. The robustness of results were validated through sensitivity analyses and a series of scenario analyses was also conducted.
RESULTS
The incremental cost-utility ratio(ICUR) of the sintilizumab plus chemotherapy group and the tislelizumab plus chemotherapy group were ¥125143.88/quality adjusted life year(QALY) and ¥189609.64/QALY, respectively, which were less than the willingness-to-pay(WTP) threshold of ¥257094/QALY, and all the ICURs of other PD-1/PD-L1 inhibitor combination regimens exceeded the WTP threshold and were not economical. Scenario analyses found that even if the medical insurance reimbursement ratio reached 80%, the different combinations of pembrolizumab, nivolumab and atezolizumab were not economical.
CONCLUSION
Compared with other PD-1/PD-L1 inhibitor combination regimens, sintilizumab plus chemotherapy and tislelizumab plus chemotherapy have cost-utility advantages in the first-line treatment of advanced NSCLC, which can provide a certain reference for selecting a reasonable treatment plan for NSCLC patients.
5.Evidence Evaluation and Rationality Analysis for Off-label Use of Tacrolimus in the Kidney Diseases in Adults
LI Xiaomin ; TAN Xinyi ; ZHANG Aobo ; ZHANG Xueli ; SHAO Hua
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1830-1835
OBJECTIVE
To evaluate the levels of evidence and analyze the rationality for off-label use of tacrolimus in the kidney diseases in adults.
METHODS
By systematically reviewing the drug instructions, clinical guidelines and medical literature of tacrolimus in the kidney diseases in adults, screening the highest level of evidence, and an evaluation table based on evidence-based medical for off-label use of tacrolimus in the kidney diseases in adults was established. Based on the evaluation table, collect adult patients from the Department of Nephrology in Zhongda Hospital Southeast University who had a medication history of off-label use of tacrolimus from January 1, 2021 to December 31, 2022, and evaluated the rationality of application for tacrolimus.
RESULTS
A total of 19 indications for off-label use of tacrolimus in the kidney diseases in adults were listed, and their recommended levels were determined based on evidence. Among them, the recommended levels for common types of kidney diseases were higher. In addition, 194 adult patients with off-label use of tacrolimus were selected from the Department of Nephrology in Zhongda Hospital Southeast University, and their application recommended levels with "strongly recommended""moderately strongly recommended""weakly recommended" and "not recommended", were 67.0%, 12.9%, 15.0% and 5.1%, respectively.
CONCLUSION
Tacrolimus has a wide range of indications for off-label use in the kidney diseases in adults, but the evidence for most common types of kidney diseases are relatively sufficient and their use are reasonable.
6.Research Progress of IL-13 Regulating Mucus Hypersecretion in Allergic Rhinitis and the Intervention of Traditional Chinese Medicine
ZHAO Yue ; WANG Zhiwang ; HUANG Keting ; LIANG Keke ; QUAN Ping ; ZHANG Yue
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1836-1843
Allergic rhinitis(AR) is an allergic inflammatory disease of the nasal mucosa in which the immune inflammatory response alters the local microenvironment of the nasal mucosa, causing mucus hypersecretion as one of the main pathological features of AR. Interleukin-13(IL-13) is the main inflammatory factor secreted by Th2 cells, it can be involved in AR mucus hypersecretion process by regulating Goblet cell proliferation and Mucin 5ac expression through various signaling pathways. Traditional Chinese medicine has obvious advantages in the treatment of AR and its mucus hypersecretion, while the IL-13-mediated signaling pathways are one of the important mechanisms in treating AR mucus hypersecretion. This article reviews the regulation of IL-13-mediated signaling pathways on AR mucus hypersecretion and the intervention effects of traditional Chinese medicine, which providing a theoretical basis for experimental research and new drug development in AR mucus hypersecretion.
7.Research Progress on Graphene Oxide Biomaterials in Transdermal Drug Delivery System
ZHANG Xin ; LIU Xiaonan ; GAO Peng
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1844-1852
With the high-speed growing demands for biomedical materials, graphene oxide(GO) and its functional derivatives show broad application prospects in the system of drug delivery, tumor therapy and nanobiology. GO has excellent hydrophilicity and easily modified surface properties, due to a large content of oxygen-containing functional groups on the GO surface. Meanwhile, the huge specific surface areas and unique π-electronic structures give GO adhesion and adsorption capacities. By means of π-π stacking, electrostatic interaction, hydrophobic interaction or covalent bonding, therapeutic agents can be effectively combined with GO to construct drug delivery systems. GO plays an important role in transdermal drug delivery systems due to their biocompatibility, antibacterial activity, and pro-wound healing activity. As a novel drug delivery system, GO nanomaterials can achieve targeted drug delivery, accumulate drug concentrations at the focal site, and improve drug delivery efficiency. Utilizing the promoting skin regeneration and wound healing properties of GO, several antibacterial materials and wound dressings are prepared for wound treatment. In addition, the special far-infrared resonance effect and electrothermal effect of GO result in heat and electric transfer. In other words, graphene oxide could control and promote transdermal absorption efficiency upon the stimuli of heat and electric. GO is expected to break through the limitation of low transdermal absorption rates in the transdermal drug delivery systems and achieve the purpose of enhancing the transdermal permeability of target molecules (especially macromolecules): ultimately improving bioavailability in vivo. This paper will introduce the structures, physicochemical properties, and biological activities of graphene oxide, summarize its application in transdermal drug delivery systems such as drug carriers, antibacterial materials, wound dressings and transdermal enhancers, and prospect its application in clinical medicine. We hope to provide new ideas and different point of views for the biomedical research of graphene oxide and derivatives. GO will become a representative biomaterial in the field of precision medicine and play a key role in the diagnosis and treatment of diseases.
8.Research Progress on Clinical Application of Chinese Herbal Pieces and Preparations for Nourishing Heart and Tranquilizing Mind
FENG Jiarui ; TU Xin ; ZHANG Yizhong ; TIAN Qi ; WONG LISOO ; LIU Lili ; BAO Kangde ; WANG Dan
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1853-1863
The upset insomnia caused by life and work pressure has seriously affected the physical and mental health of modern people and induced many diseases. The quality of Chinese medicine for nourishing heart and tranquilizing mind is stable, and it has a significant effect on the treatment of insomnia, with fewer adverse reactions, and no dependence on sedative and hypnotic as chemical drugs. The Chinese herbal pieces and preparations for nourishing heart and tranquilizing mind can be divided into psychotropic and sedative drugs according to their functions. Their active ingredients mainly include flavonoids, alkaloids, organic acids, polysaccharides, amino acids and vitamins, etc. They are mostly used in the treatment of cardiovascular diseases and central nervous system inhibition. In this paper, the types and active ingredients and development tendency and application status of the Chinese herbal pieces and preparations of nourishing heart and tranquilizing mind were reviewed individually, in order to provide reference for the development of drugs of nourishing heart and tranquilizing mind in the field of clinical application and related drugs.
9.Research Progress of Tumor Immunotherapy Target CD73 and Its Inhibitors
WANG Wenze ; CHEN Yuepeng ; CEN Lifang ; ZOU Yi ; XU Yungen
Chinese Journal of Modern Applied Pharmacy 2024;41(13):1864-1878
Adenosine has been proved to have immunosuppressive effect in many different diseases, and the activity of ecto-5’-nucleotidase(CD73) on the cell surface is the rate-limiting step of extracellular adenosine production. CD73 has a profound and lasting impact on tumor immune regulation of regulatory T cells, B cells, macrophages and natural killer cells. CD73-mediated adenosine pathway is significant in signal transduction during cancer progression in tumor microenvironment, making CD73 a novel immune checkpoint. Therefore, CD73 inhibition is a emergent and promising strategy for cancer immunotherapy. At present, a variety of monoclonal antibodies and small molecule inhibitors have been in clinical development. This review comprehensively summarizes the frontier research progress of reported small molecule CD73 inhibitors, which can provide guidance for the investigation of novel CD73 inhibitors for cancer therapy.
10.Study on the Anti-thymic Atrophy Effects of Different Extracts from Root Tubers of Tetrastigma Hemsleyanum Diels et. Gilg
XIE Zhen ; ZHANG Chenhui ; LU Jingxian ; YE Kang ; HE Licheng ; CHEN Shuhuai ; KUANG Rong ; ZHANG Jinsong ; CHEN Bilian
Chinese Journal of Modern Applied Pharmacy 2024;41(14):1913-1920
OBJECTIVE
To compare the anti-thymic atrophy effects of petroleum ether(PEE), ethyl acetate(EAE), n-butanol(BE) and water extract(WE) fractions from root tubers of Tetrastigma hemsleyanum Diels et. Gilg based on mice thymic atrophy model established by intraperitoneal injection of PolyI:C to preliminarily investigate the mechanisms of its effects.
METHODS
One hunderd ICR mice were randomly divided into 10 groups: control group, model group, low- and high-dose groups of the four extract fractions, with 10 mice in each group. The control group and model group were given equal volume of purified water and gavaged for 10 d. Starting on the 9th day, PolyI:C solution of 16 mg·kg−1 was injected intraperitoneally for 2 consecutive days, except for the control group, which was injected intraperitoneally with physiological saline. Samples of thymics were weighed and and visceral index was calculated, blood samples were taken for analysis of IL-2, TNF-α and WBC, thymic histopathology was analyzed using hematoxylin-eosin staining, Western blotting was performed to detect the expression of TNF-α, p-NF-κB and NF-κB.
RESULTS
Compared with the model group, all groups of extracts could enhance the thymus weight and thymus index, as well as the cortex and medulla area ratio and the number of thymic corpuscles in 1 mm2 of medulla to different degrees, and at the same time, significantly reduce the level of TNF-α in plasma, evidently inhibited the phosphorylation of NF-κB, and reduced the protein expression of TNF-α, and each of them having distinct advantages and disadvantages. Peripheral blood white blood cell, lymphocyte absolute count and lymphocyte percentage were elevated in the low-dose WE group, low-dose EAE group and high dose PEE group, IL-2 levels were significantly elevated in the low-dose WE group and high dose BE group, and these effects were particularly well demonstrated.
CONCLUSION
Four extracts from root tubers of Tetrastigma Hemsleyanum Diels et. Gilg can improve morphological changes and atrophy of the thymus tissue in different degrees, regulate of peripheral blood leukocyte imbalance in post-modeling mice, it may be related to the inhibition of PolyI:C-induced phosphorylation of the NF-κB and reduction of protein expression of pro-inflammatory factors.


Result Analysis
Print
Save
E-mail